ARCHIVES

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Concept Approval Given To $7 Million In OD Recompetitions, Renewals

May 28, 1982

Nevins: Duke Administration Did a “Very Good Job” Of Handling The Crisis

April 1, 2011

In Brief: Survey Finds Americans Misinformed About Leading Cause Of Cancer Death

July 10, 1998

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

November 9, 2001

Clinton Signs Bill Creating NIH Center On Minority Health.

December 1, 2000

How a two-faced media covered cancer: Promoting research—and cigarettes

April 29, 2022